http://www.unboundmedicine.com/medline/ebm/research/gefitinibUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19892771/full_citation/The_Role_of_EGFR_Inhibition_in_the_Treatment_of_Non_Small_Cell_Lung_Cancer_Ray M, Salgia R, Vokes EE 
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Oncologist 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887873/full_citation/Down_staging_of_EGFR_mutation_positive_advanced_lung_carcinoma_with_gefitinib_followed_by_surgical_intervention:_follow_up_of_two_cases_Levchenko EV, Moiseyenko VM, Matsko DE, et al. 
Down-staging of EGFR mutation-positive advanced lung carcinoma with gefitinib followed by surgical intervention: follow-up of two cases. [Journal Article, Research Support, Non-U.S. Gov't]
Onkologie 2009 Nov; 32(11):674-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19885553/full_citation/Inhibition_of_endothelial_cell_chemotaxis_toward_FGF_2_by_gefitinib_associates_with_downregulation_of_Fes_activity_Kanda S, Naba A, Miyata Y 
Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity. [JOURNAL ARTICLE]
Int J Oncol 2009 Dec; 35(6):1305-1312.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884551/full_citation/Phase_II_Study_of_Preoperative_Gefitinib_in_Clinical_Stage_I_Non_Small_Cell_Lung_Cancer_Lara-Guerra H, Waddell TK, Salvarrey MA, et al. 
Phase II Study of Preoperative Gefitinib in Clinical Stage I Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881244/full_citation/Successful_treatment_of_lung_cancer_with_gefitinib_and_EGFR_mutation_status_determination_using_EBUS_TBNA_samples_in_an_extremely_old_patient_Nishimura H, Nakajima T, Itakura M, et al. 
Successful treatment of lung cancer with gefitinib and EGFR mutation status determination using EBUS-TBNA samples in an extremely old patient. [Journal Article, Research Support, Non-U.S. Gov't]
Intern Med 2009; 48(21):1905-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19879702/full_citation/Molecular_and_Clinical_Responses_in_a_Pilot_Study_of_Gefitinib_with_Paclitaxel_and_Radiation_in_Locally_Advanced_Head_and_Neck_Cancer_Van Waes C, Allen CT, Citrin D, et al. 
Molecular and Clinical Responses in a Pilot Study of Gefitinib with Paclitaxel and Radiation in Locally Advanced Head-and-Neck Cancer. [JOURNAL ARTICLE]
Int J Radiat Oncol Biol Phys 2009 Oct 29.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19879012/full_citation/Treatment_of_advanced_non_small_cell_lung_cancer_in_the_elderly_Gridelli C, Maione P, Rossi A, et al. 
Treatment of advanced non-small-cell lung cancer in the elderly. [JOURNAL ARTICLE]
Lung Cancer 2009 Oct 28.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19865001/full_citation/Simultaneous_Quantification_of_Erlotinib_Gefitinib_and_Imatinib_in_Human_Plasma_by_Liquid_Chromatography_Tandem_Mass_Spectrometry_Chahbouni A, den Burger JC, Vos RM, et al. 
Simultaneous Quantification of Erlotinib, Gefitinib, and Imatinib in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry. [JOURNAL ARTICLE]
Ther Drug Monit 2009 Oct 27.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19854117/full_citation/Development_of_a_high_performance_liquid_chromatographic_mass_spectrometric_method_for_the_determination_of_cellular_levels_of_the_tyrosine_kinase_inhibitors_lapatinib_and_dasatinib_Roche S, McMahon G, Clynes M, et al. 
Development of a high-performance liquid chromatographic-mass spectrometric method for the determination of cellular levels of the tyrosine kinase inhibitors lapatinib and dasatinib. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 Oct 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19852530/full_citation/Gefitinib:_a_review_of_its_use_in_the_treatment_of_locally_advanced/metastatic_non_small_cell_lung_cancer_Sanford M, Scott LJ 
Gefitinib: a review of its use in the treatment of locally advanced/metastatic non-small cell lung cancer. [Journal Article]
Drugs 2009; 69(16):2303-28.
Abstract | Full Citation